Investigating the role of specific antigens in the immune response and vaccines for Valley Fever.

Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis

NIH-funded research Northern Arizona University · NIH-10899658

This study is looking at how certain parts of the Coccidioides fungus that causes Valley Fever affect the immune system, with the goal of finding better ways to diagnose and treat the disease and to help create effective vaccines for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorthern Arizona University NIH-funded
Lab location1 site (Flagstaff, United States)
Project IDNIH-10899658 on NIH RePORTER

What this research studies

This research focuses on understanding how certain antigens from the Coccidioides fungus, which causes Valley Fever, affect the immune response in patients. By studying T cell responses in both human patients and animal models, the researchers aim to identify specific T cell clones and their associated epitopes that are crucial for developing effective vaccines. The project will utilize a T cell peptide stimulation strategy to link these epitopes to their T cell receptors (TCRs), which may help improve diagnosis and treatment of Valley Fever. The ultimate goal is to enhance patient outcomes by prioritizing vaccine candidates based on these findings.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals living in areas with high prevalence of Valley Fever, particularly those experiencing symptoms that may be misdiagnosed.

Not a fit: Patients who do not reside in endemic areas or those who have already been diagnosed and treated for Valley Fever may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic methods and effective vaccines for Valley Fever, reducing misdiagnosis and unnecessary treatments.

How similar studies have performed: Previous research has shown promise in identifying immune responses to Coccidioides, suggesting that this approach may yield valuable insights.

Where this research is happening

Flagstaff, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.